Ezh2 inhibition therapies for the treatment of at-rich interactive domain-containing protein 1a (arid1a) mutated cancers
US-2026021082-A1 · Jan 22, 2026 · US
Constellation Pharmaceuticals Inc patents
Constellation Pharmaceuticals Inc holds 136 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 136 |
| Recent patents | 15 |
| First publication | Jan 8, 2015 |
| Latest publication | Jan 22, 2026 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Crystalline forms of 7-chloro-2-(4-3-methoxyazetidin-1-yl)cyclohexyl)-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide
US-12516040-B2 · Jan 6, 2026 · US
P300/cbp hat inhibitors
US-2025230137-A1 · Jul 17, 2025 · US
Modulators of trex1
US-2025136588-A1 · May 1, 2025 · US
Anhydrous crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
US-2025122217-A1 · Apr 17, 2025 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Ezh2 inhibition therapies for the treatment of at-rich interactive domain-containing protein 1a (arid1a) mutated cancers
US-2026021082-A1 · Jan 22, 2026 · US
Crystalline forms of 7-chloro-2-(4-3-methoxyazetidin-1-yl)cyclohexyl)-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide
US-12516040-B2 · Jan 6, 2026 · US
P300/cbp hat inhibitors
US-2025230137-A1 · Jul 17, 2025 · US
Modulators of trex1
US-2025136588-A1 · May 1, 2025 · US
Anhydrous crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
US-2025122217-A1 · Apr 17, 2025 · US
Top CPC classifications
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/00 | 127 |
| A61P43/00 | 51 |
| A61P35/02 | 47 |
| C07D471/04 | 42 |
| A61K45/06 | 40 |
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 131 |
| Chemistry & Metallurgy | 120 |
| Cross-Sectional Technologies | 5 |
| Physics | 4 |
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- How many patents does Constellation Pharmaceuticals Inc have in patentsdb?
- Constellation Pharmaceuticals Inc is linked to 136 publications as assignee in our database.
- What technology areas does Constellation Pharmaceuticals Inc patent most?
- Top mapped technology areas by patent count: Human Necessities (131); Chemistry & Metallurgy (120); Cross-Sectional Technologies (5).
- Is Constellation Pharmaceuticals Inc's patent activity growing?
- In our data, assignee counts were 7 in 2024 and 3 in 2025 (lower year over year).
- What are recent patents assigned to Constellation Pharmaceuticals Inc?
- See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.